grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

March 01, 2018

Omnicell Opens Center of Excellence in Cranberry Township, Showcasing Innovation and Industry-Leading Medication Management Platform

Download PDF
U.S. Representative Mike Kelly to Join Company Leadership for March 2 Dedication Ceremony

MOUNTAIN VIEW, Calif., March 1, 2018 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and adherence tools for healthcare systems and pharmacies, today announced the opening of its new Center of Excellence in Cranberry Township, PA – showcasing the company's industry-leading medication management platform through robotics, predictive analytics, and an enhanced customer briefing experience. U.S. Representative Mike Kelly, Pennsylvania 3rd district, will join Randall Lipps, chairman, president, chief executive officer, and founder of Omnicell along with other senior Omnicell executives for an opening ceremony on Friday, March 2 from 11:00 a.m. to 1:00 p.m. EST at Omnicell offices located at 500 Cranberry Woods Drive, Cranberry Township, PA.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

"Investment in new technologies and new products is an important source of economic growth for our region," said Congressman Kelly. "Omnicell's investment in healthcare technology and robotics here in western Pennsylvania further enhances our growing status as a worldwide leader in innovation." 

Earlier this year, Omnicell launched the industry's first Pharmacy Robotics Resource Center, a website promoting the knowledge, understanding, and advancement of pharmacy robotics. Complementing this effort, Omnicell enhanced its Customer Briefing Center in the Cranberry offices to include a robotics lab showcasing the evolution of robotics in medication management and ways this technology is revolutionizing the patient medication experience by eliminating manual tasks, allowing pharmacy to redirect resources to clinical activities that impact patient outcomes.

The newly renovated facility also includes a centralized intelligence and data center to house business analysis services for Performance Center partners. Here, business experts and data analysts specializing in medication management leverage a cloud-based predictive intelligence platform to review real-time information from health system partners across the country. By proactively monitoring hospitals' medication management data, the Performance Center delivers actionable insights to improve business and patient outcomes.

The Customer Briefing Center offers a collaborative environment where healthcare leaders, clinicians, and technicians can learn about the newest strategies and technologies to solve patient medication challenges. The center features Omnicell's broad portfolio of workflow automation solutions to help health systems efficiently manage medications across all care settings.

"This significant investment in local talent and resources is meant to cultivate future innovation, in partnership with our customers, to improve healthcare for everyone through our differentiated platform, workflow automation, and predictive intelligence solutions," said Lipps.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. Omnicell is revolutionizing the patient medication experience from hospital to home by empowering providers to keep each patient at the center of care. The Company's autonomous approach to medication management leverages a differentiated platform for hardware and workflow software solutions, real-time predictive intelligence, and performance-driven partnerships to help drive operational, financial, and clinical success for customers.

Supporting the highest level of patient safety is essential to excellent patient care. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on delivering solutions for medication availability, affordability, safety, and adherence. Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence, and improve patient safety.

Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient engagement and adherence to prescriptions, helping to reduce costly hospital readmissions.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc. All other brand or product names may be trademarks or registered trademarks of their respective companies.


Cision View original content with multimedia:

SOURCE Omnicell, Inc.

Betsy Martinelli, Omnicell, Inc., (724) 741-8341,; or Jessika Parry, Next Step Communications, (781) 326-1741,